Patents by Inventor Terri L. Butler

Terri L. Butler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9572882
    Abstract: The present invention relates to methods for supplementing the diet of subjects suffering from cardiovascular disease. D-Ribose is given long term alone or in combination with vasodilators in order to improve or maintain the diastolic or systolic function of the subjects.
    Type: Grant
    Filed: June 26, 2009
    Date of Patent: February 21, 2017
    Assignee: RiboCor, INC.
    Inventors: Terri L. Butler, John St. Cyr, Clarence A. Johnson
  • Publication number: 20100009924
    Abstract: The present invention relates to methods for supplementing the diet of subjects suffering from cardiovascular disease. D-Ribose is given long term alone or in combination with vasodilators in order to improve or maintain the diastolic or systolic function of the subjects.
    Type: Application
    Filed: June 26, 2009
    Publication date: January 14, 2010
    Applicant: Bioenergy, Inc.
    Inventors: Terri L. Butler, John St. Cyr, Clarence A. Johnson
  • Patent number: 7553817
    Abstract: The present invention relates to compositions for supplementing the diet of subjects suffering from cardiovascular or peripheral vascular disease or those at risk for such conditions. Ribose is given alone or in combination with one or a combination of vasodilators, nutrients and vitamins. Preferred vitamins include Vitamins C, B6, B12 and folic acid. Preferred nutrients include glutamine and glucose.
    Type: Grant
    Filed: October 23, 2003
    Date of Patent: June 30, 2009
    Assignee: Bioenergy, Inc.
    Inventors: Terri L. Butler, John St. Cyr, Clarence A. Johnson
  • Patent number: 7094762
    Abstract: The present invention relates to methods and compositions comprising ribose and maleate for the treatment of fibromyalgia syndrome. The methods and compositions of the invention are especially useful for oral administration and are useful for alleviating the symptoms of pain, fatigue, and irritable bowel syndrome in fibromyalgia syndrome.
    Type: Grant
    Filed: December 27, 2003
    Date of Patent: August 22, 2006
    Assignee: Bioenergy, Inc.
    Inventors: Terri L. Butler, Dean J. MacCarter, Daryl K. MacCarter
  • Publication number: 20040162245
    Abstract: The present invention relates to methods and compositions for the treatment of fibromyalgia. The methods and compositions of the invention are especially suitable for oral administration and are useful for alleviating the symptoms of pain, fatigue, and irritable bowel syndrome in the condition fibromyalgia.
    Type: Application
    Filed: December 27, 2003
    Publication date: August 19, 2004
    Inventors: Terri L. Butler, Dean J. MacCarter, Daryl K. MacCarter
  • Publication number: 20040147458
    Abstract: Ribose, given before and preferably also after strenuous exercise prevents or treats joint swelling due to strenuous exercise.
    Type: Application
    Filed: September 29, 2003
    Publication date: July 29, 2004
    Inventors: Richard K Van Tassel, Terri L. Butler, John St. Cyr
  • Publication number: 20040087515
    Abstract: The present invention relates to compositions for supplementing the diet of subjects suffering from cardiovascular or peripheral vascular disease or those at risk for such conditions. Ribose is given alone or in combination with one or a combination of vasodilators, nutrients and vitamins. Preferred vitamins include Vitamins C, B6, B12 and folic acid. Preferred nutrients include glutamine and glucose.
    Type: Application
    Filed: October 23, 2003
    Publication date: May 6, 2004
    Inventors: Terri L. Butler, John St. Cyr, Clarence A. Johnson
  • Patent number: 6703370
    Abstract: The present invention relates to methods and compositions comprising ribose for the treatment of fibromyalgia syndrome. The methods and compositions of the invention are especially suitable for oral administration and are useful for alleviating the symptoms of pain, fatigue, and irritable bowel syndrome in fibromyalgia syndrome.
    Type: Grant
    Filed: October 26, 2000
    Date of Patent: March 9, 2004
    Assignee: Bioenergy, Inc.
    Inventors: Terri L. Butler, Dean J. MacCarter, Daryl K. MacCarter
  • Patent number: 6663859
    Abstract: D-Ribose and methods for using D-Ribose are provided for enhancing the immune response in mammals. Those with a less than optimal immune response will benefit from oral or parenteral administration of D-Ribose. Methods are also provided for the enhancement of the immune response in isolated leukocytes. Leukocytes are cultured ex vivo in the presence of D-Ribose and transfused into a patient in need of leukocyte augmentation.
    Type: Grant
    Filed: January 8, 2001
    Date of Patent: December 16, 2003
    Assignees: Bioenergy, Inc., University of Florida
    Inventors: Susan S. Percival, Robin J. Henken, John St. Cyr, Clarence A. Johnson, Terri L. Butler
  • Patent number: 6525027
    Abstract: Ribose administered to humans performing weight-training exercise provides more rapid increase in muscle mass and decrease in body fat than weight-training exercise without ribose.
    Type: Grant
    Filed: January 19, 2001
    Date of Patent: February 25, 2003
    Assignee: Bioenergy Inc.
    Inventors: Lou Vazquez, Scott Hagerman, Terri L. Butler
  • Patent number: 6511964
    Abstract: Persons encountering high altitudes without being acclimatized can prevent or alleviate the symptoms of acute mountain sickness by administration of ribose one to four times a days, beginning immediately on encountering high altitudes and continuing for at least five days.
    Type: Grant
    Filed: March 29, 2001
    Date of Patent: January 28, 2003
    Assignee: Bioenergy, Inc.
    Inventors: Terri L. Butler, John St. Cyr, Clarence A. Johnson
  • Publication number: 20020119933
    Abstract: The present invention relates to compositions for supplementing the diet of subjects suffering from cardiovascular or peripheral vascular disease or those at risk for such conditions. Ribose is given alone or in combination with one or a combination of vasodilators, nutrients and vitamins. Preferred vitamins include Vitamins C, B6, B12 and folic acid. Preferred nutrients include glutamine and glucose.
    Type: Application
    Filed: July 27, 2001
    Publication date: August 29, 2002
    Inventors: Terri L. Butler, John St. Cyr, Clarence A. Johnson
  • Patent number: 6429198
    Abstract: Pentose is administered to mammals to increase athletic performance and reduce fatigue.
    Type: Grant
    Filed: October 3, 2000
    Date of Patent: August 6, 2002
    Assignee: Bioenergy Inc.
    Inventors: John St. Cyr, Clarence A. Johnson, Scott Hagerman, Louis W. Vasquez, Terri L. Butler
  • Publication number: 20020065232
    Abstract: Persons encountering high altitudes without being acclimatized can prevent or alleviate the symptoms of acute mountain sickness by administration of ribose one to four times a days, beginning immediately on encountering high altitudes and continuing for at least five days.
    Type: Application
    Filed: March 29, 2001
    Publication date: May 30, 2002
    Inventors: Terri L. Butler, John St. Cyr, Clarence A. Johnson
  • Publication number: 20020035069
    Abstract: Ribose administered to humans performing weight-training exercise provides more rapid increase in muscle mass and decrease in body fat than weight-training exercise without ribose.
    Type: Application
    Filed: January 19, 2001
    Publication date: March 21, 2002
    Inventors: Lou Vazquez, Scott Hagerman, Terri L. Butler
  • Publication number: 20020028196
    Abstract: D-Ribose and methods for using D-Ribose are provided for enhancing the immune response in mammals. Those with a less than optimal immune response will benefit from oral or parenteral administration of D-Ribose. Methods are also provided for the enhancement of the immune response in isolated leukocytes. Leukocytes are cultured ex vivo in the presence of D-Ribose and transfused into a patient in need of leukocyte augmentation.
    Type: Application
    Filed: January 8, 2001
    Publication date: March 7, 2002
    Inventors: Susan S. Percival, Robin J. Henken, John St. Cyr, Clarence A. Johnson, Terri L. Butler
  • Patent number: 6194106
    Abstract: This invention discloses novel surface release layers on temporary image receptors particularly suited to the requirements of liquid electrographic (both electrophotographic and electrostatic) printing on a variety of receptors. The inventive temporary image receptors are comprised of a surface release layer on a photoreceptive or dielectric substrate. The release layers are silicone copolymers which are chemically modified to improve imaging, drying or transfer performance when used in the simplified color electrophotography (SCE) or electrostatic printing processes.
    Type: Grant
    Filed: May 23, 2000
    Date of Patent: February 27, 2001
    Assignee: Minnesota Mining and Manufacturing Company
    Inventors: Kathryn R. Bretscher, Terri L. Butler, Mark C. Berens, James A. Baker, Gay L. Herman, Larry D. Boardman, Gaye K. Lehman
  • Patent number: 6106989
    Abstract: This invention discloses novel surface release layers on temporary image receptors particularly suited to the requirements of liquid electrographic (both electrophotographic and electrostatic) printing on a variety of receptors. The inventive temporary image receptors are comprised of a surface release layer on a photoreceptive or dielectric substrate. The release layers are silicone copolymers which are chemically modified to improve imaging, drying or transfer performance when used in the simplified color electrophotography (SCE) or electrostatic printing processes.
    Type: Grant
    Filed: November 30, 1999
    Date of Patent: August 22, 2000
    Assignee: 3M Innovative Properties Company
    Inventors: Kathryn R. Bretscher, Terri L. Butler, Mark C. Berens, James A. Baker, Gay L. Herman, Larry D. Boardman, Gaye K. Lehman
  • Patent number: 6020098
    Abstract: This invention discloses novel surface release layers on temporary image receptors particularly suited to the requirements of liquid electrographic (both electrophotographic and electrostatic) printing on a variety of receptors. The inventive temporary image receptors are comprised of a surface release layer on a photoreceptive or dielectric substrate. The release layers are silicone copolymers which are chemically modified to improve imaging, drying or transfer performance when used in the simplified color electrophotography (SCE) or electrostatic printing processes.
    Type: Grant
    Filed: April 4, 1997
    Date of Patent: February 1, 2000
    Assignee: Minnesota Mining and Manufacturing Company
    Inventors: Kathryn R. Bretscher, Terri L. Butler, Mark C. Berens, James A. Baker, Gay L. Herman, Larry D. Boardman, Gaye K. Lehman
  • Patent number: 5965243
    Abstract: The invention is textured surface release layers for dielectric substrates used in liquid electrostatic imaging processes. The invention also includes means of providing textured release surfaces for dielectric substrates, and a method of liquid electrostatic imaging using textured dielectric substrates.
    Type: Grant
    Filed: April 4, 1997
    Date of Patent: October 12, 1999
    Assignee: 3M Innovative Properties Company
    Inventors: Terri L. Butler, Kathryn R. Bretscher, Mark C. Berens, James A. Baker, Gaye K. Lehman